Mirjam Boelens to Cetuximab
This is a "connection" page, showing publications Mirjam Boelens has written about Cetuximab.
Connection Strength
0.046
-
Mutational profiles associated with resistance in patients with BRAFV600E mutant colorectal cancer treated with cetuximab and encorafenib +/- binimetinib or alpelisib. Br J Cancer. 2021 01; 124(1):176-182.
Score: 0.046